Table 2. Response to everolimus by disease type.
Disease type | N | ORR (95% CI) | CR | PR |
---|---|---|---|---|
Total | 77 | 30% (20–41) | 3 | 20 |
DLBCL | 47 | 30% (17–45) | 0 | 14 |
MCL | 19 | 32% (13–57) | 2 | 4 |
FL-III | 8 | 38% (9–76) | 1 | 2 |
Other | 3 | 0 | 0 | 0 |
Abbreviations: CI, confidence interval; CR, complete remission; DLBCL, diffuse large B-cell lymphoma; FL-III, follicular lymphoma grade III; MCL, mantle cell lymphoma; ORR, overall response rate; PR, partial remission.